Cytos
About:
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies .
Website: http://cytos.com/
Top Investors: Novartis, Alta Partners, HealthCap, Abingworth, Amgen Ventures
Description:
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.
Total Funding Amount:
$126M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Schlieren, Zurich, Switzerland
Founded Date:
1995-01-01
Contact Email:
info(AT)kuros.ch
Founders:
Wolfgang A. Renner
Number of Employees:
51-100
Last Funding Date:
2012-03-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai